FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 122 filers reported holding FLEXION THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $936,000 | +16.4% | 153,465 | +57.1% | 0.00% | 0.0% |
Q2 2021 | $804,000 | +88.7% | 97,672 | +105.1% | 0.00% | +50.0% |
Q1 2021 | $426,000 | +117.3% | 47,623 | +180.9% | 0.00% | +100.0% |
Q4 2020 | $196,000 | -76.5% | 16,952 | -78.9% | 0.00% | -90.9% |
Q3 2020 | $835,000 | +3.9% | 80,241 | +31.2% | 0.01% | -15.4% |
Q2 2020 | $804,000 | +148.9% | 61,155 | +49.0% | 0.01% | +62.5% |
Q1 2020 | $323,000 | -60.0% | 41,043 | +5.1% | 0.01% | +60.0% |
Q4 2019 | $808,000 | +87.5% | 39,056 | +11.4% | 0.01% | +25.0% |
Q2 2019 | $431,000 | -3.8% | 35,071 | -2.4% | 0.00% | -20.0% |
Q1 2019 | $448,000 | +209.0% | 35,927 | +181.1% | 0.01% | +150.0% |
Q4 2018 | $145,000 | -83.8% | 12,783 | -73.3% | 0.00% | -81.8% |
Q3 2018 | $895,000 | -51.0% | 47,826 | -32.4% | 0.01% | -54.2% |
Q2 2018 | $1,828,000 | +297.4% | 70,702 | +244.4% | 0.02% | +242.9% |
Q1 2018 | $460,000 | +54.4% | 20,530 | +66.6% | 0.01% | +16.7% |
Q3 2017 | $298,000 | -66.7% | 12,325 | -73.8% | 0.01% | -83.8% |
Q4 2016 | $895,000 | +143.9% | 47,033 | +92.0% | 0.04% | +60.9% |
Q2 2016 | $367,000 | – | 24,500 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Clearline Capital LP | 391,076 | $7,317,000 | 4.33% |
Rubric Capital Management LP | 2,125,000 | $39,759,000 | 4.20% |
Gagnon Advisors, LLC | 225,062 | $4,211,000 | 2.52% |
GAGNON SECURITIES LLC | 450,655 | $8,432,000 | 1.94% |
MILLER VALUE PARTNERS, LLC | 2,881,200 | $53,907,000 | 1.74% |
PECONIC PARTNERS LLC | 222,965 | $4,172,000 | 1.05% |
ARDSLEY ADVISORY PARTNERS LP | 415,000 | $7,765,000 | 1.05% |
Rhenman & Partners Asset Management AB | 532,812 | $9,969,000 | 1.00% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 574,483 | $10,749,000 | 0.75% |
Kerrisdale Advisers, LLC | 37,145 | $695,000 | 0.68% |